Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, please find enclosed herewith certificate received from KFIN Technologies Limited, Registrar & Share ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mahamaya Lifesciences Ltd has submitted a certificate received from its Registrar & Share Transfer Agent, KFIN Technologies Limited, as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 December 2025. KFIN Technologies confirmed that the regulation is not applicable to the company because the entire shareholding is held in dematerialised (demat) form. No requests for re-materialisation of shares were received from any member during the quarter. The certificate was signed by KFIN Technologies on 14 January 2026 and submitted to BSE by the company's Company Secretary on 16 January 2026.
This is a routine procedural compliance filing with no material impact on the company's financials, operations, or share price. It simply confirms that all shares of the company are held in demat form and no share re-materialisation requests were processed during the quarter.